Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 675.20
Bid: 679.40
Ask: 680.20
Change: 7.00 (1.05%)
Spread: 0.80 (0.118%)
Open: 666.00
High: 683.60
Low: 643.40
Prev. Close: 668.20
ENT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (Entain PLC / DraftKings Inc)

5 Oct 2021 11:40

RNS Number : 0777O
Entain PLC
05 October 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

ENTAIN PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ENTAIN PLC (OFFEREE)

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

4 OCTOBER2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES: DRAFTKINGS INC (OFFEROR)

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

ORDINARY SHARES

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0.000

Nil

0.000

(2) Cash-settled derivatives:

 

Nil

0.000

Nil

0.000

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0.000

Nil

0.000

 

TOTAL:

Nil

0.000

Nil

0.000

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

NONE

Details, including nature of the rights concerned and relevant percentages:

NONE

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

1. Interests held by directors of Entain and their close relatives and related trusts (excluding the options and awards set out below):

 

Entain director / close relatives / related trusts

Number of ordinary shares

% of issued ordinary share capital*

Jette Nygaard-Andersen

9,900

0.00169

Rob Wood

18,000

0.00307

John Wood (Rob Wood's father)

1,000

0.00017

Wood Family Trust (Rob Wood's father's trust for the benefit of family members)

6,500

0.00111

Robert Hoskin

12,010

0.00205

Sian Hoskin (wife of Robert Hoskin)

486

0.00008

Barry Gibson

27,210

0.00464

Brenda Gibson (wife of Barry Gibson)

39,277

0.00670

Pierre Bouchut

38,500

0.00657

Peter Isola

36,135

0.00616

Virginia McDowell

15,000

0.00256

Sandeep Tiku

8,972

0.00153

*Figures are rounded to 5 decimal places.

 

2. Options and awards held by directors of Entain in Entain shares:

 

Long Term Incentive Plan, Restricted Stock Awards and Conditional Share Awards

 

Director

Number of ordinary shares

Date of grant

Award price (pence)

Vesting date

Robert Hoskin

56,939

20/09/2018

0

20/09/2021

Robert Hoskin

180,886

26/03/2019

0

26/03/2022

Robert Hoskin

119,160

10/06/2020

0

10/06/2023

Robert Hoskin

65,573

24/03/2021

0

24/03/2024

Sian Hoskin (wife of Robert Hoskin)

2,545

10/06/2020

0

10/06/2023

Sian Hoskin (wife of Robert Hoskin)

1,393

24/03/2021

0

24/03/2024

Rob Wood

27,519

20/09/2018

0

20/09/2021

Rob Wood

197,044

26/03/2019

0

26/03/2022

Rob Wood

136,803

10/06/2020

0

10/06/2023

Rob Wood

 

86,065

 

24/03/2021

0

24/03/2024

Jette Nygaard-Andersen

147,540

24/03/2021

0

24/03/2024

Sandeep Tiku

13,755

28/12/2017

0

28/12/2020

Sandeep Tiku

72,235

26/03/2019

0

26/03/2022

Sandeep Tiku

52,090

10/06/2020

0

10/06/2023

Sandeep Tiku

49,180

24/03/2021

0

24/03/2024

 

Deferred Bonus Plan

 

Director

Number of Entain Shares

Date of grant

Award price (pence)

Vesting date

Rob Wood

39,067

10/06/2020

0

10/06/2023

3. Interests held by connected advisors of Entain in Entain:

 

Entain concert party

Number of ordinary shares

% of issued ordinary share capital**

Parametric Portfolio Associates LLC***

256,876

0.0438

 

Entain concert party

Number of American depositary receipts

% of issued ordinary share capital**

Parametric Portfolio Associates LLC***

309,100

0.0528

 

**Figures are rounded to 4 decimal places.

***Position as at the close of business on 1 October 2021.

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 October 2021

Contact name:

Emily Carey, Company Secretary

 

Telephone number:

+44 7929 850134

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEFSEFSIEFSEDS
Date   Source Headline
21st May 20247:00 amRNSCapital Allocation Committee Update
3rd May 202411:44 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 20243:03 pmRNSDirector/PDMR Shareholding
29th Apr 20247:00 amRNSSuccessful repricing of Term Loans & £600m add-on
26th Apr 20249:56 amRNSBoard Committee Changes
24th Apr 202412:09 pmRNSResult of AGM
17th Apr 20247:00 amRNSQ1 Trading Update
16th Apr 20249:17 amRNSTR1: Notification of Major Holdings
4th Apr 20247:00 amRNSChairman Succession
2nd Apr 20247:00 amRNSBlock Listing Six Monthly Return
2nd Apr 20247:00 amRNSTotal Voting Rights
22nd Mar 20247:42 amRNSAnnual Report, AGM and Gender Pay Gap Report
12th Mar 202411:41 amRNSDirector/PDMR Shareholding
12th Mar 202410:00 amRNSBoard Appointment
11th Mar 20241:54 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFY23 results in line with expectations
1st Mar 20247:00 amRNSTotal Voting Rights
19th Feb 20247:00 amRNSTR1: Notification of Major Holdings
8th Feb 20242:00 pmRNSBETMGM FY23 UPDATE
6th Feb 20242:00 pmRNSNotice of BetMGM FY 2023 update
2nd Feb 20244:11 pmRNSNew Board Committee
1st Feb 20247:00 amRNSTotal Voting Rights
3rd Jan 20249:27 amRNSTR1: Notification of Major Holdings
3rd Jan 20247:00 amRNSBoard Appointment
2nd Jan 20248:29 amRNSTotal Voting Rights
15th Dec 20234:00 pmRNSBoard Committee Changes
13th Dec 20237:00 amRNSDirectorate Change
6th Dec 202310:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSBetMGM at Morgan Stanley Consumer Conference
5th Dec 20232:06 pmRNSFinal Approval of Deferred Prosecution Agreement
4th Dec 20232:00 pmRNSBetMGM Business Update
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 202310:42 amRNSStatement regarding KSA decisions
27th Nov 20232:00 pmRNSBetMGM Business Update Event Details
24th Nov 20232:01 pmRNSUpdate on Deferred Prosecution Agreement
15th Nov 202311:00 amRNSDirector/PDMR Shareholding
8th Nov 20232:00 pmRNSTR1: Notification of Major Holdings
8th Nov 20237:00 amRNSDirector/PDMR Shareholding
7th Nov 20233:39 pmRNSTR1: Notification of Major Holdings
6th Nov 20239:12 amRNSTR1: Notification of Major Holdings
2nd Nov 20237:00 amRNSQ3 Trading Statement & Business Update
1st Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSBoard Appointment
4th Oct 20232:00 pmRNSNotice of BETMGM Business Update Event
4th Oct 202311:30 amRNSTR1: Notification of Major Holdings
2nd Oct 202312:35 pmRNSBlock Listing Six Monthly Return
2nd Oct 20239:11 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSCompletion of acquisition of Angstrom Sports
25th Sep 20237:00 amRNSUpdate on current trading and operational strategy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.